DIA will host the 3rd Annual Latin American Regulatory Conference: Harmonization of Regulatory Requirements in Drug Development and Registration from April 12-15, 2011 in Panama City, Panama. This four-day conference will discuss the progress of the PANDRH harmonization process and attempt to define the global regulatory environment and its impact on access to medicine and the future of R&D in Latin America. Specific discussion topics will include:
- Current Environment for Regulatory Authorities and Industry for Latin America
- Harmonization Initiatives, Regulatory Landscape and Clinical Trials in the Latin American Region
- Good Clinical Research Practice
- Drug Safety, Good Clinical and Regulatory Practices Across Latin America
- Transparency and Predictability
“From an evolving series of Latin American Regulatory Conferences (LARC) held in May 2008 and November 2009 comes this alliance for key stakeholders to influence the advancement for harmonization initiatives within the Latin American local regions,” says Latin American Steering Committee Member Sergio Guerrero, MD, Director, OCA Hospital/Monterrey International Research Center, Mexico.
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. www.diahome.org